In vitro drug release from macromolecule-drug conjugates of 3'-(7-carboxyheptanoyl)-5-fluoro-2'-deoxyuridine with decylenediamine-dextran T70 or poly-L-lysine.
- 1 January 1987
- journal article
- research article
- Published by Pharmaceutical Society of Japan in CHEMICAL & PHARMACEUTICAL BULLETIN
- Vol. 35 (8) , 3370-3374
- https://doi.org/10.1248/cpb.35.3370
Abstract
3'- (7-Carboxyheptanoyl) -5-fluoro-2'-deoxyuridine (C6-FUdR) was conjugated to decylenediamine-dextran T70 (T70-C10) or poly-L-lysine (PLL) by using 1-ethyl-3- (3-dimethylaminopropyl) -carbodiimide hydrochloride (EDC). Drug release patterns from the conjugates between C6-FUdR and T70-C10 (T70-C10-C6-FUdR) or PLL (PLL-C6-FUdR) by enzymatic and nonenzymatic processes were investigated at neutral and weakly acidic pHs. Under the nonenzymatic conditions, 5-fluoro-2'-deoxyuridine (FUdR) was released slowly only at neutral pH. This property is similar to that of C6-FUdR. Gradual drug release was observed enzymatically from T70-C10-C6-FUdR at both pHs, while PLL-C6-FUdR did not show enzymatic drug release. However, after the treatment of PLL-C6-FUdR with trypsin, FUdR was released enzymatically from the products; in this case, the release rate of FUdR was faster at neutral pH than at the weakly acidic pH. However, the release of FUdR by enzymatic processing was much slower from these conjugates than from C6-FUdR.Keywords
This publication has 6 references indexed in Scilit:
- Novel Preparation of Decylenediamine-dextran T70 and Inhibitory Activity toward Dihydrofolate Reductase of Decylenediaminedextran T70-Methotrexate ConjugateCHEMICAL & PHARMACEUTICAL BULLETIN, 1987
- Specificity of esterases and structures of prodrug esters. III. Activity of rat tissue homogenates, rat plasma and porcine liver esterase for the hydrolysis of 3',5'-bis-dicarboxylic acid hemiesters of 5-fluoro-2'-deoxyuridine.CHEMICAL & PHARMACEUTICAL BULLETIN, 1985
- ENHANCED LYMPHATIC DELIVERY OF MITOMYCIN-C CONJUGATED WITH DEXTRAN1984
- A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: in vitro and in vivo studies.Proceedings of the National Academy of Sciences, 1982
- Antineoplastic activity of poly(L-lysine) with some ascites tumor cells.Proceedings of the National Academy of Sciences, 1979
- POLY (L-LYSINE) AND POLY (D-LYSINE) CONJUGATES OF METHOTREXATE - DIFFERENT INHIBITORY EFFECT ON DRUG-RESISTANT CELLS1979